Image 1SpecificationsOrganism/cell line/tissue*S. aureus BUSA2288* (*Nasal isolate*)Sex*NA*Sequencer or array type*MiSeq*Data format*Raw*Experimental factors*Blue light illumination vs no light*Experimental featuresRNA-Seq was used to analyze the differential gene expression of *S. aureus* in culture in response to blue light exposure.Consent*IRB Baylor University*Sample source location*NA*

1. Direct link to deposited data \[provide URL below\] {#s0005}
======================================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62055>

2. Experimental design, materials and methods {#s0010}
=============================================

\[complete description of the Experimental design and methods used to acquire the genomic data and where applicable, in the analysis. Include any relevant figures/tables.\]

2.1. Bacterial isolate {#s0015}
----------------------

A methicillin resistant isolate of *S. aureus* was cultured from the nasal passage of a healthy Baylor University student in Waco, TX during the fall of 2009. This isolate is referred to as BUSA2288. Baylor University\'s Institutional Review Board for the protection of human subjects approved the consent form, collection procedures, and recording methods. The nasal passage sample was collected by swabbing each anterior nare and gently rolling the swab across the surface of a mannitol salt agar plate. Fermenting colonies were isolated and purified on tryptic soy agar (TSA) plates. Gram positive, catalase positive, coagulase positive, staphylococcal cultures were identified as *S. aureus* and stored in CRYOCARE beads (Key Scientific Products, Stamford, Texas) for future use. A Kirby Bauer disc diffusion assay was performed on *S. aureus* BUSA2288 and oxacillin resistance was confirmed using Etest (bioMérieux, Inc., Durham, NC) and positive PCR amplification of the *nuc* and *MecA* genes [@bb0020].

2.2. Growth conditions {#s0020}
----------------------

BUSA2288 was grown overnight in 5 ml of Brain Heart Infusion (BHI) broth at 37 °C. The broth culture was inoculated from a single colony grown on a TSA plate. The contents of this overnight culture were added to 45 ml BHI broth resulting in a concentration of approximately 1 × 108 CFU/ml as measured by colony counts. 1 ml aliquots of this diluted overnight culture was transferred to each well of two BD Falcon™ non-treated 24-well plates. The control plate, labeled No Light (NL), was covered and protected from light, and the treatment plate, labeled Blue Light (BL), was illuminated. Both plates were incubated with shaking at 35 °C for 2 h.

2.3. Light source {#s0025}
-----------------

The illumination box was designed and constructed in house. Twenty-four 1.5 mm Kingbright blue LED lights were attached to a 24-well plate lid. The lights were arranged so that when the modified lid was place on a 24-well plate the lights were 0.5 mm above the broth of the individual wells as seen in [Fig. 1](#f0005){ref-type="fig"}. The LED lights are CIE 127 compliant with a dominant wavelength of 465 nm and a 2θ 1/2 of 16° [@bb0005] The lights were operated at a forward current of 20 mA for 2 h resulting in a total light dosage per well of 250 J/cm^2^. The resistors were placed away from the light box so as to not increase the temperature inside of the incubator.

2.4. RNA extraction and mRNA enrichment {#s0030}
---------------------------------------

Total RNA was extracted from the NL control and BL treatment samples using a modified phenol chloroform extraction method as follows. The culture was removed from 24 wells and centrifuged. The pelleted cells were resuspended in RNAse free water and incubated with an equal volume of 1:1 phenol/chloroform (\~ 250 μl each). After a 30 min incubation at 70 °C, the phases were separated by centrifugation at 12,000 ×* g* for 10 min. The aqueous layer was removed (\~ 200 μl) and 2x the volume of isopropanol was added followed by refrigerated centrifugation at 12,000 ×* g* for 10 min. The RNA pelleted was washed with 200 μl of cold 70% ethanol and centrifuged at 8000 ×* g* for 10 min. The pellet was dried in the inverted tube at room temperature for 10 min and resuspended in 95 °C Elution Buffer Solution (Ambion). Both samples were treated with DNAse Inactivation Reagent (Ambion). The mRNA was enriched following the protocols provided with the MICROBExpress Bacterial mRNA Enrichment Kit (Ambion). This procedure uses a capture hybridization by magnetic beads to remove 16S and 23S ribosomal RNAs. The purity and concentration of the total and enriched RNA samples were analyzed by gel electrophoresis and by an Agilent Bioanalyzer. Complementary DNA libraries were built and sequenced using the Illumina MiSeq Next Generation Sequencer at the University of Oklahoma Health Science Center\'s lab for Molecular Biology and Cytometry Research.

2.5. RNA-seq data analysis {#s0035}
--------------------------

Two independent experiments were performed and sequenced. Whole genome sequencing has not been performed on BUSA2288, so in order to determine which reference genomes to use for alignment we performed an alignment using BLAST and determined the two closest related reference genomes. High quality reads were then aligned to the genomes of MRSA252 (NC_002952) and N315 (NC_002745), in order to create a transcriptome map.

In one analysis, the combined results of both independent experiments were analyzed using the Pairwise Analysis tools in Gene Sifter® [@bb0015]. The genes were normalized by Mapped Reads using EdgeR statistics including a Benjamini and Hochberg false discovery rate correction. The Quality was set at a minimum number of 10 reads and the lower threshold for change was 5 fold, with a p-value of 0.05 or less. These criteria produced a list of 32 up or down regulated genes as shown in [Table 1](#t0005){ref-type="table"}.

2.6. Conclusions {#s0040}
----------------

One hypothesis regarding the mechanism of blue light inhibition is that the interaction of blue light with intracellular or membrane bound molecules, results in production of reactive oxygen species and cell death [@bb0010]. This data indicates that there is a genetic response to the blue light involving the oxidative stress pathways. Whether this is a specific or general response is an important question to explore, since polymorphism exists at many of these alleles. This data provides a starting point for further exploration. It is possible that a small molecule acting to up or down regulate one or more of these pathways may provide a new antimicrobial. The raw data files for the RNA-seq experiment are deposited in the GEO, Gene accession GSE62055.

Transparency document {#s0045}
=====================
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![Blue light box. The light box was built in house using Kingbright LED lights and an adjustable power supply [@bb0005].](gr1){#f0005}

###### 

Differentially regulated genes.

Table 1

  Functional category and gene                                                gene                        MRSA252 Locus   *n*-fold change   *P*-value
  --------------------------------------------------------------------------- --------------------------- --------------- ----------------- -----------
  1\. Biosynthesis of amino acids                                                                                                           
  aspartate semialdehyde dehydrogenase                                        *asd*                       SAR1406         − 5.54            4.41E-03
  aspartate kinase                                                            *lysC*                      SAR1405         − 5.3             7.70E-03
  2\. Cell envelope components                                                                                                              
  sortase                                                                     *srtB*                      SAR1108         5.03              9.45E-03
  3\. Cellular processes                                                                                                                    
  serine protease                                                             *splC*                      SAR1906         7.45              1.49E-02
  4\. Central intermediary metabolism                                                                                                       
   Nitrate reductase subunit alpha                                            *narG*                      SAR2486         − 5.88            5.96E-03
   Nitrate reductase subunit beta                                             *narH*                      SAR2485         − 5.88            5.96E-03
   Nitrate reductase gamma chain                                              *NarI*                      SAR2483         − 5.88            5.96E-03
   Respiratory nitrate reductase delta chain                                  *narJ*                      SAR2484         − 5.88            5.96E-03
   Small heat shock protein                                                   *narK*                      SAR2475         − 9.24            1.25E-03
   Nitrite transport protein                                                  *narT*                      SAR2476         − 9.24            1.44E-03
   Nitrite reductase large subunit                                            *nasD*                      SAR2489         − 5.46            2.50E-02
   Assimilatory nitrite reductase small subunit                               *nasE*                      SAR2488         − 6.15            1.20E-02
   Tetrapyrrole (corrin/porphyrin) methylase                                  *nasF*                      SAR2487         − 6.15            1.20E-02
  5\. Energy metabolism                                                                                                                     
   Azoreductase                                                               *acpD*                      SAR0203         28.06             1.79E-02
   Dioxygenase                                                                *PcpA*\_*N*\_*like*         SAR2599         18.32             1.14E-02
  6\. Protein synthesis                                                                                                                     
   Aminoacyl-tRNA biosynthesis                                                *tRNA-Asp*                  SARt023         − 10.13           4.01E-02
  7\. Regulatory function                                                                                                                   
   Accessory gene regulator B                                                 *agrB*                      SAR2123         − 8.03            5.29E-04
   Nitrogen regulatory protein A                                              *nreB*                      SAR2482         − 5.56            1.38E-02
   Response regulator                                                         *nreC*                      SAR2480         − 5.68            3.52E-02
   Dissimilatory nitrate/nitrite reduction) two-component regulatory system   *NreB-NreC*                 SAR2481         − 5.88            2.24E-02
   RNAIII regulatory transcript/delta haemolysin                              *RNAIII*                    SARs022         − 9.88            2.38E-04
  8\. conserved protein, unknown function                                     Pfam prediction                                               
   Hypothetical protein                                                       SepA                        SAR2259         − 8.38            3.47E-05
   Hypothetical protein                                                       YceI-like                   SAR2769         11.74             3.47E-02
   Hypothetical protein                                                       CbiX, CbiK, DUF3928         SAR2490         − 7.13            9.08E-03
   Hypothetical protein                                                       Pig-F GPI biosynthesis      SAR0742         − 5.64            1.13E-02
   Hypothetical protein                                                       Trep-Strep                  SAR1005         − 5.76            3.68E-03
   Hypothetical protein                                                       DoxX, DoxX_2                SAR1010         − 5.64            9.06E-03
   Hypothetical protein                                                       bPH_5                       SA2264          − 7.11            1.77E-03
   Hypothetical protein                                                       DUF5080, HRG                SAR0291         − 6.24            3.48E-04
   Hypothetical protein                                                       DUF4293, RTA1, Serinc       SAR0292         − 6.31            5.52E-03
   Hypothetical protein                                                       Ycf1                        SAR2683         − 5.7             5.96E-03
   Hypothetical protein                                                       Putative membrane protein   SAR0455         − 5.51            4.12E-02
